Inogen (INGN) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.49% |
| Dec 31, 2025 | -9.66% |
| Sep 30, 2025 | -13.21% |
| Jun 30, 2025 | -12.77% |
| Mar 31, 2025 | -13.38% |
| Dec 31, 2024 | -15.42% |
| Sep 30, 2024 | -15.80% |
| Jun 30, 2024 | -14.73% |
| Mar 31, 2024 | -12.83% |
| Dec 31, 2023 | -10.95% |
| Sep 30, 2023 | -9.28% |
| Mar 31, 2023 | -5.65% |
| Dec 31, 2022 | -3.26% |
| Sep 30, 2022 | 1.83% |
| Jun 30, 2022 | 5.20% |
| Mar 31, 2022 | 6.93% |
| Dec 31, 2021 | 9.20% |
| Sep 30, 2021 | 12.82% |
| Jun 30, 2021 | 14.41% |
| Mar 31, 2021 | 16.69% |
| Dec 31, 2020 | 18.86% |
| Sep 30, 2020 | 19.49% |
| Mar 31, 2020 | 26.35% |
| Dec 31, 2019 | 27.85% |
| Sep 30, 2019 | 28.15% |
| Jun 30, 2019 | 26.91% |
| Mar 31, 2019 | 29.01% |
| Dec 31, 2018 | 32.58% |
| Sep 30, 2018 | 31.38% |
| Jun 30, 2018 | 28.38% |
| Mar 31, 2018 | 26.41% |
| Dec 31, 2017 | 25.22% |
| Sep 30, 2017 | 25.30% |
| Jun 30, 2017 | 19.98% |
| Mar 31, 2017 | 18.87% |
| Dec 31, 2016 | 37.47% |